Serrano-Oviedo, L.; Ortega-Muelas, M.; García-Cano, J.; Valero, M.L.; Cimas, F.J.; Pascual-Serra, R.; Fernandez-Aroca, D.M.; Roche, O.; Ruiz-Hidalgo, M.J.; Belandia, B.; Giménez-Bachs, J.M.; Salinas, A.S.; Sanchez-Prieto, R. "Autophagic cell death associated to Sorafenib in renal cell carcinoma is mediated through Akt inhibition in an ERK1/2 independent fashion.". PLoS ONE. 13(7): e0200878. (2018). (PMID: 30048489).
Meléndez-Rodríguez, F.; Roche, O.; Sanchez-Prieto, R.; Aragones, J. "Hypoxia-Inducible Factor 2-Dependent Pathways Driving Von Hippel-Lindau-Deficient Renal Cancer.". Front Oncol. 8(): 214. (2018). (PMID: 29938199).
Cimas, F.J.; Callejas-Valera, J.L.; García-Olmo, D.C.; Hernández-Losa, J.; Melgar-Rojas, P.; Ruiz-Hidalgo, M.J.; Pascual-Serra, R.; Ortega-Muelas, M.; Roche, O.; Marcos, P.; Garcia-Gil, E.; Fernandez-Aroca, D.M.; Ramón Y Cajal, S.; Gutkind, J.S.; Sanchez-Prieto, R. "E1a is an exogenous in vivo tumour suppressor.". Cancer Lett.. 399(): 74-81. (2017). (PMID: 28416454).
Roche, O.; Deguiz, M.L.; Tiana, M.; Galiana-Ribote, C.; Martinez-Alcazar, D.; Rey-Serra, C.; Ranz-Ribeiro, B.; Casitas, R.; Galera, R.; Fernández-Navarro, I.; Sánchez-Cuéllar, S.; Bernard, V.; Ancochea, J.; Wasserman, W.W.; García-Rio, F.; Jimenez, B.; Del Peso, L. "Identification of non-coding genetic variants in samples from hypoxemic respiratory disease patients that affect the transcriptional response to hypoxia.". Nucleic Acids Res.. (): . (2016). (PMID: 27625398).
García-Cano, J.; Roche, O.; Cimas, F.J.; Pascual-Serra, R.; Ortega-Muelas, M.; Fernández-Aroca, D.M.; Sánchez-Prieto, R. "p38MAPK and Chemotherapy: We Always Need to Hear Both Sides of the Story.". Front Cell Dev Biol. 4(): 69. (2016). (PMID: 27446920).
Instituto de Investigaciones Biomédicas "Alberto Sols"
C/Arturo Duperier 4. 28029 Madrid. (Spain)
Tel +(34) 91 585 4400 // Fax +(34) 91 558 4401 Email:Info